661 - Phase 1, dose-escalation trial of the safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies (DMAb) in healthy adults

Presenting Author(s)

• PT

  Pablo Tebas, MD

  MD
  University of Pennsylvania
  Merion Station, PA, United States

  Slides

Co-Author(s)

• AP

  Ami Patel, PhD

  Wistar Institute
  Philadelphia, Pennsylvania, United States
• JA

  Joseph Agnes, PhD

  INOVIO Pharmaceuticals
  Plymouth Meeting, Pennsylvania, United States
• EP

  Elizabeth M Parzych, PhD

  Wistar Institute
  Philadelphia, Pennsylvania, United States
• AB

  Amanda Baer, MB, MBA

  University of Pennsylvania
  Philadelphia, Pennsylvania, United States
• MC

  Maria Caturla, PharmD

  University of Pennsylvania
  Philadelphia, Pennsylvania, United States
• SG

  Sukanya Ghosh, PhD

  Wistar Institute
  philadelphia, Pennsylvania, United States
• MP

  Mansi Purwar, PhD

  Postdoctoral Fellow
  Wistar Institute
  philadelphia, Pennsylvania, United States
• NB

  Nicole Bedanova, PhD

  Wistar Institute
  Philadelphia, Pennsylvania, United States
• cT

  chungdhak Tsang, BS

  University of Pennsylvania
  Philadlephia, Pennsylvania, United States
• KM

  Knashawn Morales, PhD

  Wistar Institute
  Philadelphia, Pennsylvania, United States
• DA

  Dinah Amante, BS

  INOVIO Pharmaceuticals
  Plymouth Meeting, Pennsylvania, United States
• PF

  Paul D Fisher, PhD

  Inovio Pharmaceuticals
  Plymouth Meeting, Pennsylvania, United States
• JF

  Joe Francica, PhD

  AstraZeneca
  Gaithersburg, Maryland, United States
• LH

  Laurent Humeau, PhD

  INOVIO Pharmaceuticals
  Plymouth Meeting, Pennsylvania, United States
• JP

  Jesper Pallesen, PhD

  Wistar Institute
  Philadelphia, Pennsylvania, United States
• PL

  Paul Eric Leon, PhD

  AstraZeneca
  Gaithersburg, Maryland, United States
• 

  Mark T. Esser, PhD

  Vice President of Vaccines and Immune Therapies early R&D
  AstraZeneca
  Gaithersburg, MD, United States
• TS

  Trevor RF Smith, PhD

  Inovio Pharmaceuticals
  Plymouth Meeting, Pennsylvania, United States
• DW

  David B Weiner, PhD

  Wistar Institute
  Philadelphia, Pennsylvania, United States